Comment on draft of atopic dermatitis pediatric guidelines
The AAD is seeking member comments on draft clinical practice guidelines on the management of atopic dermatitis (AD) in children and adolescents. These guidelines provide evidence-based recommendations regarding the primary prevention of AD, the association between AD and selected comorbidities among children and adolescents, and the management of AD with topical therapies, phototherapy, and systemic therapies. The development of these guidelines followed a systematic approach, and recommendations were formed by a guideline work group that included experts in AD management from multiple clinical settings, methodologists, and a patient representative.
Please note that the guideline content is provided in two manuscripts.
The comment period is open to all AAD members, and comments are being accepted through Oct. 27, 2025. Feedback received will be provided to the guideline development work group for review.
If you have questions, please email Lindsy Frazer-Green at lfrazer-green@aad.org.
Draft guideline and supplement
There are four PDFs available for review.
Guidelines of care for the management of atopic dermatitis in pediatric patients
Download the draft guideline itself.
Access the supplement to the guideline.
Guidelines of care for the primary prevention of atopic dermatitis and awareness of 3 comorbid conditions in pediatric atopic dermatitis
Download the draft guideline itself.
Access the supplement to the guideline.
